Meridian Bioscience Market Cap 2006-2019 | VIVO

Meridian Bioscience market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Meridian Bioscience market cap as of December 05, 2019 is $0.39B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.391B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.187B 27.21
Medtronic (MDT) Ireland $148.912B 20.55
Stryker (SYK) United States $75.969B 25.54
Boston Scientific (BSX) United States $59.391B 28.03
Baxter (BAX) United States $41.360B 25.08
Essilor Luxottica (ESLOY) France $32.912B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.495B 18.50
Terumo (TRUMY) Japan $27.172B 33.91
Coloplast (CLPBY) Denmark $25.315B 39.07
Lonza Group Ag (LZAGY) Switzerland $25.204B 0.00
ResMed (RMD) United States $21.492B 39.65
Smith & Nephew SNATS (SNN) United Kingdom $19.178B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.378B 541.29
Bio-Rad Laboratories (BIO) United States $11.123B 53.39
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.077B 20.87
Perrigo (PRGO) Ireland $6.765B 12.61
Canopy Growth (CGC) Canada $6.616B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $5.992B 40.49
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
ICU Medical (ICUI) United States $3.819B 24.90
NuVasive (NUVA) United States $3.787B 29.82
Neogen (NEOG) United States $3.465B 57.97
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.150B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.132B 0.00
Quidel (QDEL) United States $2.821B 26.77
Aurora Cannabis (ACB) Canada $2.691B 0.00
National Vision Holdings (EYE) United States $2.343B 52.89
Agios Pharmaceuticals (AGIO) United States $2.303B 0.00
Cardiovascular Systems (CSII) United States $1.547B 0.00
InMode (INMD) Israel $1.406B 0.00
Aphria (APHA) $1.192B 0.00
AtriCure (ATRC) United States $1.173B 0.00
VAREX IMAGING (VREX) United States $1.126B 22.55
Phibro Animal Health (PAHC) United States $0.980B 18.35
NanoString Technologies (NSTG) United States $0.937B 0.00
Lantheus Holdings (LNTH) United States $0.791B 19.75
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.79
TG Therapeutics (TGTX) United States $0.778B 0.00
LeMaitre Vascular (LMAT) United States $0.719B 40.43
Omeros (OMER) United States $0.715B 0.00
Quanterix (QTRX) United States $0.707B 0.00
PetIQ (PETQ) United States $0.645B 15.73
Cerus (CERS) United States $0.589B 0.00
Surmodics (SRDX) United States $0.561B 58.56
HEXO (HEXO) $0.555B 0.00
OraSure Technologies (OSUR) United States $0.478B 28.67
MacroGenics (MGNX) United States $0.455B 0.00
Organigram Holdings (OGI) Canada $0.442B 0.00
Owens & Minor (OMI) United States $0.416B 15.40
Utah Medical Products (UTMD) United States $0.392B 28.37
Zynex (ZYXI) United States $0.351B 39.67
BioLife Solutions (BLFS) United States $0.329B 134.08
Neptune Wellness Solutions (NEPT) Canada $0.257B 0.00
United Health Products (UEEC) United States $0.256B 0.00
Bovie Medical (APYX) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.230B 24.28
Vapotherm (VAPO) United States $0.225B 0.00
Repro-Med Systems (KRMD) United States $0.192B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Chimerix (CMRX) United States $0.167B 0.00
InfuSystems Holdings (INFU) United States $0.162B 814.00
Female Health (VERU) United States $0.142B 0.00
Rockwell Medical (RMTI) United States $0.138B 0.00
MTech Acquisition (KERN) United States $0.137B 0.00
Fonar (FONR) United States $0.127B 8.93
Cytosorbents (CTSO) United States $0.126B 0.00
United-Guardian (UG) United States $0.091B 23.08
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.065B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00